Breaking News, Promotions & Moves

Biomira, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Robert L. Kirkman, M.D. has been named president and chief executive officer of Biomira and was also elected to the board of directors. The company has named Christopher Henney, Ph.D. chairman of the board. Dr. Kirkman was formerly acting president and chief executive officer of Xcyte Therapies, Inc of Seattle, WA, which concluded a merger with Cyclacel Pharmaceuticals, Inc., in March 2006. From 2004-2005, Dr. Kirkman was chief business officer and vice president at Xcyte and from 1998 to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters